Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulodexide for type 2 diabetic nephropathy with macroalbuminuria
ChiCTR-TRC-09000559Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2014
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) comparing Placebo group with Sulodexide group (2 arms). Primary endpoints: Albumin-to-creatinine ratio change and Improvement. Started Sep 2014; status: completed.
02
Drugs
sulodexide
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-09000559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000559.